Coronavirus mutations: what we've learned so far
Risk Off: USDX Leaps 0.64% Amid Coronavirus Concern
Political interference fears mount as Trump backs Pfizer’s COVID vaccine
Futures Rebound As Tech Gains; Powell, Mnuchin To Speak In Congress
US Open – Winter stimulus needed
US Suffers Most New COVID-19 Cases In 5 Weeks As Doctors Warn Of "Apocalyptic" Fall: Live Updates
TikTok says it removed 104M videos in H1 2020, proposes harmful content coalition with other social apps
Tension amid calm as the FTSE 100 awaits new restrictions due to Covid-19
Lies, Damned Lies, & UK Health Statistics: The Deadly Danger Of False Positives
Stock market contagion spreads
Daily market commentary: The pound is continuing to depreciate versus its peers
Fears Of 2nd UK Lockdown Intensify, California 3rd State To Top 15,000 COVID-19 Deaths: Live Updates
Key Events This Week: Powell Speaks Not Once, Not Twice, But Three Times
Global Stocks Plunge On Bank, Election, Virus Fears; Treasuries, Dollar Spike
HSBC collapses in Hong Kong under pressure from several fronts
Oil gains ground, gold consolidates
AstraZeneca-Merck’s Lynparza Gets Recommended By EU For Prostate, Ovarian Cancers
Risk Appetites Join Tokyo on Vacation
Weekly Market Outlook: Central banks and PMI figures in focus
It was the Best of Times, It was the Worst of Times
France Suffers Most COVID-19 Deaths Since Spring; Finance Minister Tests Positive: Live Updates
18/9/20: COVID19 Update: Countries with more than 100,000 cases
Week Ahead – No ease up for Powell
Russia approves first Covid-19 prescription drug for sale in pharmacies
Moderna Says COVID-19 Vaccine Won't Be Widely Available Until 2021 As US Deaths Near 200,000: Live Updates
1 In 5 Are Looking For A New Career Path Post-Lockdown
Moderna Publishes COVID-19 Vaccine Trial "Blueprint" To Quiet Concerns About Rushed Approval
Main European indices fall, dragged down by the tourism sector
AstraZeneca’s Imfinzi Trial Shows Survival In Lung Cancer Patients
Pound Rallies on Brexit Deal Hopes and Upbeat UK Retail Sales